2m 2m 2m 2m 2m 2m 2m
WARBY PARKER-A (WRBY)
NYSE
$25.67+$0.03 (+0.12%)
Price as of Jun 23, 2026 7:53 PM EDT- $2.9BMarket Cap
- 18.48%1-Year Change
- Medical Instruments & SuppliesIndustry
WARBY PARKER-A (WRBY)
$25.67+$0.03 (+0.12%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 871.9M +13.04% | 771.3M +15.16% | 669.8M +11.98% | 598.1M +10.60% | |
Cost of Revenue | 401.3M +16.50% | 344.5M +13.11% | 304.5M +18.48% | 257.1M +15.24% | |
Gross Profit | 470.6M +10.25% | 426.8M +16.87% | 365.2M +7.08% | 341.1M +7.34% | |
Sales and Marketing Expense | 475.9M +4.15% | 456.9M +4.51% | 437.2M -3.33% | 452.3M -1.98% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 50.3M +9.63% | 45.9M +18.96% | 38.6M +21.00% | 31.9M +45.71% | |
Total Operating Expenses | 401.3M +16.50% | 344.5M +13.11% | 304.5M +18.48% | 257.1M +15.24% | |
Operating Profit | -5.3M -82.28% | -30.1M -58.18% | -72.0M -35.26% | -111.2M -22.59% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 8.4M -20.93% | 10.6M +14.79% | 9.2M +606.35% | 1.3M +476.66% | |
Income before Taxes | 3.0M +115.59% | -19.5M -68.91% | -62.8M -42.89% | -109.9M -23.69% | |
Income Taxes | 1.4M +60.23% | 875,000 +102.08% | 433,000 -12.88% | 497,000 +88.97% | |
Extraordinary Items | 557,000 -31.74% | 816,000 -74.74% | 3.2M +96.11% | 1.6M N/A | |
Net Income | 1.6M +108.05% | -20.4M -67.74% | -63.2M -42.75% | -110.4M -23.48% | |
Net Income from Continuing Operations Applicable to Common | 1.6M +108.05% | -20.4M -67.74% | -63.2M -42.75% | -110.4M -29.87% | |
Basic EPS and Net Income | 0.01 +105.88% | -0.17 -68.52% | -0.54 -43.75% | -0.96 -56.56% | |
Diluted EPS and Net Income | 0.01 +105.88% | -0.17 -68.52% | -0.54 -43.75% | -0.96 -56.56% | |
Basic Weighted Average Shares | 122.7M +1.90% | 120.4M +2.55% | 117.4M +2.13% | 114.9M +61.32% | |
Diluted Weighted Average Shares | 125.1M +3.92% | 120.4M +2.55% | 117.4M +2.13% | 114.9M +61.32% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 286.4M +12.67% | 254.2M +17.18% | 216.9M +3.98% | 208.6M -18.65% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 286.4M +12.67% | 254.2M +17.18% | 216.9M +3.98% | 208.6M -18.65% | |
Total Current Assets | 352.4M +8.09% | 326.0M +9.18% | 298.6M +1.38% | 294.6M -10.19% | |
Accumulated Depreciation | 205.3M +29.42% | 158.6M +36.95% | 115.8M +31.08% | 88.4M +38.75% | |
Property and Plant and Equipment and Net | 187.4M +9.96% | 170.5M +11.90% | 152.3M +9.89% | 138.6M +23.56% | |
Total Long-Term Assets | 10.2M +17.62% | 8.7M +23.24% | 7.1M -16.96% | 8.5M +1,704.03% | |
Total Assets | 720.9M +6.57% | 676.5M +16.57% | 580.3M +2.04% | 568.7M +29.06% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 150.1M +15.17% | 130.4M +2.57% | 127.1M -1.90% | 129.6M +9.70% | |
Total Long-Term Debt | 2.2M 0.00% | 2.2M -12.00% | 2.5M N/A | N/A N/A | |
Total Long-Term Liabilities | 1.3M +38.92% | 943,000 -25.40% | 1.3M -24.40% | 1.7M N/A | |
Total Liabilities | 353.2M +4.99% | 336.4M +20.79% | 278.5M -1.25% | 282.1M +82.39% | |
Retained Earnings | -685.6M -0.24% | -687.2M +3.06% | -666.8M +10.47% | -603.6M +22.38% | |
Total Stockholders Equity | 367.7M +8.13% | 340.1M +12.69% | 301.8M +5.28% | 286.6M +0.23% | |
Total Shares Outstanding | 106.3M -12.02% | 120.8M +2.28% | 118.2M -48.78% | 230.7M +1.51% | |
Cash Flow | |||||
Cash from Operating Activities | 110.8M +12.19% | 98.7M +61.90% | 61.0M +488.15% | 10.4M +132.41% | |
Capital Expenditures | 67.0M +4.71% | 64.0M +19.30% | 53.7M -10.82% | 60.2M +24.05% | |
Cash from Investing Activities | -67.0M +1.54% | -66.0M +20.78% | -54.7M -9.16% | -60.2M +24.05% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -12.0M -341.83% | 5.0M +72.80% | 2.9M -12.76% | 3.3M -85.69% | |
Financials Ratio | |||||
Gross Margin | 53.97% -2.47% | 55.34% +1.48% | 54.53% -4.37% | 57.02% N/A | |
Operating Margin | -0.61% -84.32% | -3.90% -63.68% | -10.75% -42.18% | -18.59% N/A | |
Return on Assets | 0.23% +107.24% | -3.24% -70.50% | -11.00% -49.71% | -21.87% N/A | |
Return on Equity | 0.46% +107.30% | -6.35% -70.42% | -21.48% -44.29% | -38.56% N/A | |
Revenue Growth | 13.04% -13.99% | 15.16% +26.56% | 11.98% +13.04% | 10.60% N/A | |
Current Ratio | 2.35 -6.14% | 2.50 +6.45% | 2.35 +3.34% | 2.27 N/A | |
Cash Ratio | 1.91 -2.17% | 1.95 +14.25% | 1.71 +6.00% | 1.61 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow